Insights

Focus on Oncology Elevar Therapeutics specializes in developing advanced therapies for complex and under-treated cancers such as hepatocellular carcinoma and adenoid cystic carcinoma, indicating significant opportunities to collaborate with healthcare providers and hospitals seeking innovative cancer treatment options.

Strategic Partnerships The company's partnership with Jiangsu Hengrui for rivoceranib suggests a global approach to drug development and commercialization, opening avenues for international distribution channels and joint ventures in emerging markets.

Strong Leadership Recent hires of key executives in medical, regulatory, and financial roles demonstrate a strategic focus on strengthening internal capabilities, creating potential for tailored healthcare solutions and expanding your engagement in clinical and regulatory affairs.

Innovative Pipeline Elevar's ongoing development of monotherapy options and combination therapies for cancers presents opportunities for collaboration in clinical trials, licensing agreements, or co-marketing initiatives with pharmaceutical and biotech companies specializing in oncology.

Growing Market Presence With revenue estimates between $50 million and $100 million and a focus on innovative treatments for underserved patient populations, Elevar is positioned for expansion—making it a promising target for sales efforts aimed at healthcare providers, research institutions, and pharmaceutical distributors.

Elevar Therapeutics Tech Stack

Elevar Therapeutics uses 8 technology products and services including Cloudflare, Microsoft 365, Apple iCloud Mail, and more. Explore Elevar Therapeutics's tech stack below.

  • Cloudflare
    Content Management System
  • Microsoft 365
    Email
  • Apple iCloud Mail
    Email
  • Priority Hints
    Performance
  • Cloudflare Bot Management
    Security
  • Animate.css
    UI Frameworks
  • TouchSwipe
    Web Tools And Plugins
  • waitForImages
    Web Tools And Plugins

Media & News

Elevar Therapeutics's Email Address Formats

Elevar Therapeutics uses at least 2 format(s):
Elevar Therapeutics Email FormatsExamplePercentage
FLast@elevartherapeutics.comJDoe@elevartherapeutics.com
72%
First.Last@elevartherapeutics.comJohn.Doe@elevartherapeutics.com
9%
FirstLast@elevartherapeutics.comJohnDoe@elevartherapeutics.com
4%
LastFirst@elevartherapeutics.comDoeJohn@elevartherapeutics.com
3%
Last_First@elevartherapeutics.comDoe_John@elevartherapeutics.com
2%
FirstLas@elevartherapeutics.comJohnDoe@elevartherapeutics.com
2%
Last.F@elevartherapeutics.comDoe.J@elevartherapeutics.com
2%
FiLast@elevartherapeutics.comJoDoe@elevartherapeutics.com
2%
LastFir@elevartherapeutics.comDoeJoh@elevartherapeutics.com
1%
First_Last@elevartherapeutics.comJohn_Doe@elevartherapeutics.com
1%
Last@elevartherapeutics.comDoe@elevartherapeutics.com
1%
FirstMLas@elevartherapeutics.comJohnMDoe@elevartherapeutics.com
1%

Frequently Asked Questions

What is Elevar Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Elevar Therapeutics's official website is elevartx.com and has social profiles on LinkedInCrunchbase.

What is Elevar Therapeutics's NAICS code?

Minus sign iconPlus sign icon
Elevar Therapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Elevar Therapeutics have currently?

Minus sign iconPlus sign icon
As of December 2025, Elevar Therapeutics has approximately 44 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Operating Officer: S. J.Chief Financial Officer: W. S.Vice President , Human Resources: T. M.. Explore Elevar Therapeutics's employee directory with LeadIQ.

What industry does Elevar Therapeutics belong to?

Minus sign iconPlus sign icon
Elevar Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Elevar Therapeutics use?

Minus sign iconPlus sign icon
Elevar Therapeutics's tech stack includes CloudflareMicrosoft 365Apple iCloud MailPriority HintsCloudflare Bot ManagementAnimate.cssTouchSwipewaitForImages.

What is Elevar Therapeutics's email format?

Minus sign iconPlus sign icon
Elevar Therapeutics's email format typically follows the pattern of FLast@elevartherapeutics.com. Find more Elevar Therapeutics email formats with LeadIQ.

When was Elevar Therapeutics founded?

Minus sign iconPlus sign icon
Elevar Therapeutics was founded in 2019.

Elevar Therapeutics

Pharmaceutical ManufacturingNew Jersey, United States11-50 Employees

Elevar Therapeutics is a fully integrated biopharmaceutical company built on the promise of elevating treatment experiences and outcomes for patients who have limited or inadequate therapeutic options. 

Our experience is rooted in oncology, and we apply the same rigor and diligence that comes with this knowledge to identifying and developing promising medicines for complex yet under-treated health conditions across a range of therapeutic areas.

Elevating Outcomes: 
	We take a relentless and inventive approach towards developing and 
        advancing next-generation, best-in-class therapies that have the 
        potential to set new standards of care and improve treatment 
        experiences.

Evolving Therapeutic Potential: 
	We identify areas where we can develop, build upon or evolve medicines 
        that offer patients improved clinical outcomes. 

Engaging With Purpose: 
	We are committed to engaging with the highest ethical standards, driven 
        by a passion to address the underserved needs of patients, caregivers, 
        and healthcare providers.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2019
Employees
11-50

Section iconFunding & Financials

  • $50M$100M

    Elevar Therapeutics's revenue is estimated to be in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Elevar Therapeutics's revenue is estimated to be in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.